Cincinnati Children's helped test Kymriah, the first CAR-T therapy the FDA approved.
Nine years later, a Sharonville center is helping prepare the next generation of engineered immune cells.
You're likely to see more news soon about CAR-T cell therapy, which turns a patient's own immune cells against cancer. It falls under the category of "personalized…
